NCT Number: NCT03218033
Use of Social Media to Improve Medication Adherence in Adolescents and Young Adults With Systemic Lupus
The goal of this study was to examine the effect of an online educational program with and without a social media experience.The primary goal of this study was to determine whether medication adherence would be improved by having adolescents and young adults with systemic lupus erythematosus participate in an online educational website, with or without a social media experience. The secondary goal was to determine whether secondary outcomes such as quality of life, stress, and self-efficacy improved in this model, and whether these changes were associated with improvements in medication management.
Looking for future studies?
Notify MeKey information
Conditions
Age range
13 year–23 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
About this study
Self-management skills, including medication management, are vital to the health of adolescents and young adults with systemic lupus erythematosus (SLE). Non-adherence with medications in patients with systemic lupus has been noted to be as poor as 40%. Success in disease control can be significantly impacted by such non-adherence. Poor medication compliance is associated with higher SLE disease activity scores and higher SLE disease activity in turn has been demonstrated to be significantly associated with a decline in quality of life. Much attention has been paid to how to improve self-management skills in adults, but less is known about how to target adolescents, an age group with a complex set of emotional and developmental needs.
The goal of this study was to examine the effect of an online educational program with and without a social media experience.The primary goal of this study was to determine whether medication adherence would be improved by having adolescents and young adults with SLE participate in an online educational website, with or without a social media experience. The secondary goal was to determine whether secondary outcomes such as quality of life, stress, and self-efficacy improved in this model, and whether these changes were associated with improvements in medication management.
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- age between 13 and 23 at the time of recruitment
- having the diagnosis of SLE made or confirmed by a pediatric or adult rheumatologist at Penn State Children's Hospital/Hershey Medical Center
- having regular internet access.
Exclusion criteria
- age <13 or >23 years
- comorbid medical or psychiatric illness that would affect the outcome measures.
Treatment and study plan
Primary outcomes
-
Medication Adherence
Time frame: 6 months
A medication possession ratio was calculated based on fill date information from the subjects' pharmacies
Secondary outcomes
-
Stress utilizing the Perceived Severity of Stress Questionnaire
Time frame: 14 weeks
Stress was measured by the Perceived Severity of Stress Questionnaire (PSQ)
-
Self-efficacy utilizing the Children's Arthritis Self-Efficacy scale
Time frame: 14 weeks
Self-efficacy was measured using the Children's Arthritis Self-Efficacy scale (CASE) which was modified slightly for systemic lupus
-
Quality of Life utilizing the Simple Measure of the Impact of Lupus Erythematosus in Youngsters (SMILEY) index
Time frame: 14 weeks
Quality of life was assessed using the validated Simple Measure of the Impact of Lupus Erythematosus in Youngsters (SMILEY) index
-
Sense of agency
Time frame: 14 weeks
Sense of agency (SOA) was measured via three Likert scale questions aimed to tap three core concepts of agency: competence ("Blogging… makes me feel I have control over my own voice"), assertiveness ("…enables me to assert myself"), and confidence ("…makes me feel I have a distinct voice")
-
Sense of community
Time frame: 14 weeks
Sense of community (SOC) was measured using a 22-item scale (8, 9, 20). SOC consists of feelings of belonging to the community, having influence on, and being influenced by, the community, being supported by the community while also supporting them; and feelings of shared emotional connection.
-
Empowerment
Time frame: 14 weeks
Empowerment was assessed using a validated quantitative Likert scale tool that measured 1) "empowering processes" (Appendix A), and 2) "empowering outcomes"
Sponsors and collaborators
Lead sponsor
Milton S. Hershey Medical Center
Other
Collaborators
- Children's Miracle Network
- Lupus Foundation of America
Registry information
Official study title
Improvement of Medication Adherence in Adolescents With SLE Using Web-based Education With and Without a Social Media Intervention
Important dates
- Study start
- 2014
- Primary completion
- 2015
- Study completion
- 2015
- First posted
- Jul 14, 2017
- Registry last updated
- Jul 14, 2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
ASA Patterns for Prevention of Preeclampsia in SLE Pregnancies
NCT03749044
Female Urogenital Diseases and Pregnancy Complications, Hypertension, Pregnancy-Induced
Montreal, Quebec, Canada
View Trial DetailsCombined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease
NCT03762824
Arthritis, Arthritis, Rheumatoid
View Trial DetailsImmune Adsorption Role in Treatment of Resistant Lupus
NCT04108611
Systemic Lupus
Alexandria, Sidi Beshr, Egypt
View Trial DetailsYellow Fever Vaccine in Patients With Rheumatic Diseases
NCT03430388
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Aortic Arch Syndromes
São Paulo, Brazil
View Trial Details